Publicidad
Caso clínico 21 de noviembre de 2012

Valoración de metástasis cerebrales de carcinoma pulmonar mediante PET-RM como guía terapéutica

Referenciar Imprimir Descargar PDF

Referencias

  1. Baum RP, Hellwing D, Mezezeti M. Position of nuclear medicine modalities in the diagnosis workup of cancer patients: lung cancer. Q J Nucl Med Mol Imaging 2004;48:119-42.
  2. Silvestri GA, Tanoue LT, Margolis ML, et al. The non-invasive staging of non-small cell lung cancer. The guidelines. Chest 2003; 123 (Suppl 1):147S-56S.
  3. Brink I, Scgumacher T, Mix M, et al. FDG-PET in the primary staging of small-cell lung cancer. Eur J Nucl Med Mol Imaging 2004;31:1614-20.
  4. Chao ST, Suh JH, Raja S, et al. The sensitivity and specificity of FDG PET in distinguishing recurrent brain tumor from radionecrosis in patients treated with sterotactic radiosurgery. Int J Cancer 2001;96:191-7.
  5. Belohlávek O, Simonova G, KantorovaI, et al. Brain metastases after stereotactic radiosurgery using Leksell gamma Knife; can FDG PET help to differentiate radionecrosis from tumor progression? Eur J Nucl Med 2003;39:996-1000.
  6. Rohren EM, Lowe VJ. Update in PET imaging of non-small cell lung cancer. Semin Nucl Med 2004;34:134-53.
  7. Asensio C, Perez-Castejon MJ, Maldonado A, et al. The role of PET-FDG in questionnable of relapse in the presence of radionecrosis of brain tumors. Rev Neurol 1998; 27:447-52.